Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria
Recruiting now
Conditions studied: Chronic Urticaria
In brief
This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.
Key facts
- Study ID
- NCT07680413
- Run by
- Bharat Serums and Vaccines Limited
- People needed
- 600
- Starts
- 2025-12-31
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2026-07-02
Who can join
Age: 13 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female patients aged ≥13 years.
- Able and willing to provide written informed consent (or assent where applicable).
- Diagnosed with chronic urticaria with UAS7 prior to enrollment already on first line of treatment for Chronic Urticaria
- Prescribed Histoglob injections for the first time at the discretion of treating physician as part of routine car
You may not qualify if…
- Known allergy or hypersensitivity to Histoglob or human immunoglobulin product.
- Patients with acute allergic attack
- Pregnant or lactating women.
- History of malignancy or any condition requiring immunosuppressive therapy other than study indication.
- Participation in any other clinical study.
- Any other condition or circumstance that, in the opinion of the study physician, makes the patient unsuitable for study participation
Where it is running
- Vaishnavis skin Care & Cosmetic — Ahmedabad, Gujarat, India (enrolling)
- Matis Multispeciality Hospital — Ahmedabad, Gujarat, India (enrolling)
- L. G. Hospital — Ahmedabad, Gujarat, India (enrolling)
- Jupiter Hospital and Research Centre — Vadodara, Gujarat, India (enrolling)
- Parikh Multispeciality Hospital — Vadodara, Gujarat, India (enrolling)
- DRG Skin Clinic — Faridabad, Haryana, India (enrolling)
- Silver Streak Multispeciality Hospital — Gurgaon, Haryana, India (enrolling)
- Aarvya Hospital — Gurgaon, Haryana, India (enrolling)
- KIMS hospital — Bangalore, Karnataka, India (enrolling)
- SkinXperts Super Speciality Skin, Hair and Laser Clinic — Bangalore, Karnataka, India (enrolling)
- Medstar Speciality Hospital — Bangalore, Karnataka, India (enrolling)
- KR hospital — Mysore, Karnataka, India (enrolling)
- Ishwar Institute of Healthcare — Aurangabad, Maharashtra, India (enrolling)
- Renukai Critical Care and Multispeciality Hospital — Nanded, Maharashtra, India (enrolling)
- D. Y. Patil Medical College and Research Centre — Navi Mumbai, Maharashtra, India (enrolling)
- Sai Allergy Asthma Eye Hospital — Pune, Maharashtra, India (enrolling)
- Ayushri Multispeciality Hospital. — Pune, Maharashtra, India (enrolling)
- Vaidya Skin Care Clinic — Pune, Maharashtra, India (enrolling)
- Saikrupa Hospital — Pune, Maharashtra, India (enrolling)
- Anand Multispeciality Hospital — Pune, Maharashtra, India (enrolling)
- Lifepoint Multispeciality Hospital — Pune, Maharashtra, India (enrolling)
- Mediskin Hospital — Pune, Maharashtra, India (enrolling)
- Medipoint Hospital — Pune, Maharashtra, India (enrolling)
- Chandni Hospital Private Limited — Kanpur, National Capital Territory of Delhi, India (enrolling)
- Dr Astha Sharma Clinic — New Delhi, National Capital Territory of Delhi, India (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.